A new era for tumour diagnostics in digital cytology
Our mission is to make cancer diagnostics objective and scalable with AI, enabling early detection and better patient outcomes.
Our technology advances digital cytology and unlocks a major opportunity in AI-driven healthcare.
We will be attending Digital Pathology
and AI Congress 10-11th December, London, UK
Come and meet us!
*
Come and meet us! *
01
Modern scanning technology has made it possible to digitize pathological microscopic preparations with Whole Slide Image (WSI).
However, liquid cytological samples remain a technological challenge: standard autofocus and multilayer Z-Stack scanning often fail to focus on individual specific cells and place unreasonable demands on the storage of huge Z-Stack images.
Slides containing multiple layers, requiring manual scrolling, which slows down diagnostics and increases the risk of missed insights.
The Problem
02
The Solution
Our patented cIToStackᵀᴹ technology provides an automatic focus of individual cells and lossless compression of cytological scans. Overall WSI data size is reduced, while primary cell data is preserved without loss, and the optimized data can be used for further Digital Image Analysis.
Vendor neutral solution, designed to work with currently available digital scanners
Autofocus for Cell A
Autofocus for Cell B
Scaled overview
03
Benefits
01
Lower data storage and hardware costs, while primary cell data is preserved without loss
Lower Cost
02
Less time needed as you only need to focus where needed
Improve Efficiency
03
Increased confidence that cells have not been missed
Increase Confidence
Contact Us
We’re currently fundraising and so if you would like to see our pitch deck or book a meeting to discuss further, please get in touch with Milan, our Co-Founder!
Meet the team
Dr. Ondřej Sobek, MD, PhD, MIAC
Co-Founder, Medical Lead
Clinical neurocytologist with three decades of medical experience, head of Laboratory for CSF, Neuroimmunology, Pathology and Special Diagnostics - Clinical laboratory accredited according to EN ISO 15189 with annual turnover of more than 10,000 CSF samples.
Ondrej is a member of the Czech Society of Clinical Cytology committee, an expert in cerebrospinal fluid cytology assessment within EQA/SEKK-CZ, and a member of the expert team at the National Center for Electronic Health at the Czech Ministry of Health.He leads the charge in digital cytology innovation by pioneering AI- driven digital cytology and precision diagnostics.
Milan Prochazka
Co-Founder, Strategy & Investment Expert
Strategic investor with a track record in managing multi-sector investments across healthcare, media, real estate, and energy, leverages his extensive capital markets expertise from emerging markets to scale disruptive health-tech solutions.
Jan Dupač, PhD
Technology Development Lead
Jan is PhD with background in computer vision and image analysis both in research and application.
Sarah Bond, DPhil
Commercialisation Expert
An experienced Executive leader in Healthcare and Medical Devices. Experienced in delivering healthcare and medical technology products, and passionate about commercialising innovative technologies with products that are evidenced-based, and deliver clinical value.
Prof. Jaroslava Dušková, MD, PhD, FIAC
Medical Expert
World-renowned cytopathologist with experience both in clinical medical practice and in scientific research and teaching at the university. Author of many scientific publications and lectures, President of the Czech Society of Clinical Cytology.
News section
